Page last updated: 2024-08-21

dronabinol and Local Neoplasm Recurrence

dronabinol has been researched along with Local Neoplasm Recurrence in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Brazil, L; Checketts, D; Jove, M; Miller, S; Sabel, M; Short, SC; Tayo, B; Twelves, C1
Andradas, C; Arribas, J; Bernadó-Morales, C; Bibic, L; Blasco-Benito, S; Caffarel, MM; Canals, M; Canela, EI; Caro-Villalobos, M; Casadó, V; Diez-Alarcia, R; Guzmán, M; Hernández, L; Homar-Ruano, P; Manso, L; McCormick, PJ; Moreno, E; Moreno-Bueno, G; Pérez-Gómez, E; Sánchez, C; Seijo-Vila, M; Tundidor, I; Urigüen, L1
Blázquez, C; Duarte, MJ; Galve-Roperh, I; González-Feria, L; Guzmán, M; Ravina, J; Rosa, MC; Sánchez, C; Velasco, G1

Trials

2 trial(s) available for dronabinol and Local Neoplasm Recurrence

ArticleYear
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma.
    British journal of cancer, 2021, Volume: 124, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Combinations; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oral Sprays; Precision Medicine; Survival Analysis; Temozolomide; Treatment Outcome

2021
A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.
    British journal of cancer, 2006, Jul-17, Volume: 95, Issue:2

    Topics: Adult; Aged; Biopsy; Brain Neoplasms; Cannabinoid Receptor Antagonists; Cell Proliferation; Disease Progression; Dronabinol; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Receptors, Cannabinoid; Safety; Survival Rate; Treatment Outcome; Tumor Cells, Cultured

2006

Other Studies

1 other study(ies) available for dronabinol and Local Neoplasm Recurrence

ArticleYear
Therapeutic targeting of HER2-CB
    Proceedings of the National Academy of Sciences of the United States of America, 2019, 02-26, Volume: 116, Issue:9

    Topics: Breast Neoplasms; Cell Line, Tumor; Dronabinol; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Protein Multimerization; Proto-Oncogene Proteins c-cbl; Receptor, Cannabinoid, CB2; Receptor, ErbB-2; Signal Transduction

2019
chemdatabank.com